Oligomerix's Series B Round

Oligomerix raised a round of funding on May 22, 2013.

Oligomerix is a biopharmaceutical company focused on development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers and their newly discovered proteolyti…

Articles about Oligomerix's Series B Round: